← Leaderboards
Olachi Joy Mezu-Ndubuisi
University Of Wisconsin-Madison
$1,188,910
Attributed
$1,188,910
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $244.3K · FY2021–25$250K$187.5K$125K$62.5K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,188,910 · 1
By mechanism
K08$1,188,910 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Wisconsin-Madison
Same institution · by research overlap
- Ismail S Zaitoun$2,391,108
- Samuel H. Gellman$18,204,025
- Lianwang Guo$8,850,010
- Ahmed I Mahmoud$1,638,881
- Ian Bird$1,517,105
Others in their field
Other Emerging Leaders on “Diabetes Mellitus”
- Barbara Halina Braffett · George Washington University$22,016,904
- Ionut Bebu · George Washington University$18,816,779
- Bradley G Hammill · Duke University$15,773,864
- Francisco S Sy · University Of Nevada Las Vegas$11,999,607
- Gary Fanger · Rise Therapeutics, Llc$11,687,853
- Leigh A Johnson · University Of North Texas Hlth Sci Ctr$11,320,710
Research focus
Diabetes MellitusDoseAngiogenesisAdultAffectApoptosisAppointmentArterial TortuosityBevacizumabBindingAngiogenic ProteinsBiologicalBiometryBlindnessBlood CapillariesBlood VesselsCalcitriolCareerCataractCentral Retinal ArteryChildhoodClinical TranslationBiochemistryEffective Therapy
Grant awards (5)
Mechanism of intravitreal VEGF-A165a and topical calcitriol for the treatment of retinopathy of prematurity$236,140
K08 · FY2025 · EY · contact PI
Mechanism of intravitreal VEGF-A165a and topical calcitriol for the treatment of retinopathy of prematurity$236,140
K08 · FY2024 · EY · contact PI
Mechanism of intravitreal VEGF-A165a and topical calcitriol for the treatment of retinopathy of prematurity$236,140
K08 · FY2023 · EY · contact PI
Mechanism of intravitreal VEGF-A165a and topical calcitriol for the treatment of retinopathy of prematurity$236,144
K08 · FY2022 · EY · contact PI
Mechanism of intravitreal VEGF-A165a and topical calcitriol for the treatment of retinopathy of prematurity$244,346
K08 · FY2021 · EY · contact PI